Altesa BioSciences News and Activities

Acquisition, funding and merger involving Altesa BioSciences.

• Altesa BioSciences has just announced a $75 Million fundraising (posted on February 19 2026).

View the org chart displaying its 21 main executives

Most searched biographies at Altesa BioSciences

• Brett Giroir, Chief Executive Officer
• Moncef Slaoui, Board Member
• Nick Williams, Director

Popular executive movements at Altesa BioSciences

• Gwen Skloot has joined the company as Senior Vice President for Clinical Development  (posted on June 3 2026).
• Brett Haumann has joined the company as Director  (posted on June 3 2026).

Create your alert
to follow the executive moves at Altesa BioSciences.

Altesa BioSciences has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Altesa BioSciences

• Expanded Access Policy | Altesa BioSciences
• News | Altesa BioSciences
• News | Altesa BioSciences

Social media about Altesa BioSciences

• Altesa BioSciences on Wikipedia, Google News & Yahoo Finance
• Altesa BioSciences on LinkedIn, X (Twitter) & YouTube